Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 19801 AL 19815

Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease

Borghi R, Piccini A, Barini E, Cirmena G, Guglielmotto M, Tamagno E, Fornaro M, Perry G, Smith MA, Garuti A, Tabaton M.

J Alzheimers Dis. 2010;22(3):771-5. doi: 10.3233/JAD-2010-100729.

Does inorganic mercury play a role in Alzheimer's disease? A systematic review and an integrated molecular mechanism

Mutter J, Curth A, Naumann J, Deth R, Walach H.

J Alzheimers Dis. 2010;22(2):357-74. doi: 10.3233/JAD-2010-100705.

Do amyloid β-associated factors co-deposit with Aβ in mouse models for Alzheimer's disease?

Timmer NM, Kuiperij HB, de Waal RM, Verbeek MM.

J Alzheimers Dis. 2010;22(2):345-55. doi: 10.3233/JAD-2010-100711.

Regulation of in vitro Aβ1-40 aggregation mediated by small molecules

Kim HY, Kim Y, Han G, Kim DJ.

J Alzheimers Dis. 2010;22(1):73-85. doi: 10.3233/JAD-2010-100183.

Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls

Westman E, Wahlund LO, Foy C, Poppe M, Cooper A, Murphy D, Spenger C, Lovestone S, Simmons A.

J Alzheimers Dis. 2010;22(1):171-81. doi: 10.3233/JAD-2010-100168.

Intranasal insulin as a therapeutic option in the treatment of cognitive impairments

Benedict C, Frey WH 2nd, Schiöth HB, Schultes B, Born J, Hallschmid M.

Exp Gerontol. 2011 Feb-Mar;46(2-3):112-5. doi: 10.1016/j.exger.2010.08.026. Epub 2010 Sep 16.

Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients

Morillas-Ruiz JM, Rubio-Perez JM, Albaladejo MD, Zafrilla P, Parra S, Vidal-Guevara ML.

J Neurol Sci. 2010 Dec 15;299(1-2):175-8. doi: 10.1016/j.jns.2010.08.050. Epub 2010 Sep 20.

Patch-based segmentation using expert priors: application to hippocampus and ventricle segmentation

Coupé P, Manjón JV, Fonov V, Pruessner J, Robles M, Collins DL.

Neuroimage. 2011 Jan 15;54(2):940-54. doi: 10.1016/j.neuroimage.2010.09.018. Epub 2010 Sep 17.

The utility of Stroop task switching as a marker for early-stage Alzheimer's disease

Hutchison KA, Balota DA, Duchek JM.

Psychol Aging. 2010 Sep;25(3):545-59. doi: 10.1037/a0018498.

Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain

Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA.

J Neurochem. 2010 Dec;115(5):1077-89. doi: 10.1111/j.1471-4159.2010.07002.x. Epub 2010 Oct 5.

[Therapeutic strategies for Alzheimer disease based on endoplasmic reticulum stress]

Kudo T.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):163-8.

[Immunotherapy and Alzheimer's disease]

Arai H.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):173-6.

[Drug development for tauopathy and Alzheimer's disease]

Takashima A.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2010 Aug;30(4):177-80.

Review: disruption of the postsynaptic density in Alzheimer's disease and other neurodegenerative dementias

Gong Y, Lippa CF.

Am J Alzheimers Dis Other Demen. 2010 Nov;25(7):547-55. doi: 10.1177/1533317510382893. Epub 2010 Sep 21.

Cholinergic central system, Alzheimer's disease, and anesthetics liaison: a vicious circle?

Schifilliti D, Santamaria LB, Rosa G, Di Nino G, Mandal PK, Fodale V.

J Alzheimers Dis. 2010;22 Suppl 3:35-41. doi: 10.3233/JAD-2010-101317.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias